There is evidence that reduced BDNF secretion (Egan et al., 2003; Chen et al., 2004), as well as altered functional and structural connectivity of prefrontal cortical areas (Liu et al., 2012; Kim et al., 2013) may be linked to Met carriers, which may presumably render greater neurocognitive vulnerability to depression. Here, BDNF is linked to depressive symptom measurement.